All Stories

  1. Marburg virus outbreak: a global health threat, zoonotic risks, and the urgent need for international action
  2. Neuroprotective effects of Centella asiatica against LPS/amyloid beta-induced neurodegeneration through inhibition of neuroinflammation
  3. New Insights in Antibiotic Resistance and Pneumococcal Vaccines
  4. Pneumococcal Vaccination for Children
  5. Decoding the role of large heat shock proteins in the progression of neuroinflammation‐mediated neurodegenerative disorders
  6. Antibody-Dependent Enhancement During Japanese encephalitis virus Infection
  7. Clinical Characteristics and Differential Clinical Diagnosis of Japanese Encephalitis
  8. Co-infection with Other Flaviviruses During Japanese Encephalitis
  9. Global Trends in Phylogenetic Genotype-Based Epidemiology of Japanese encephalitis virus
  10. Host Immune Response During Japanese encephalitis virus Infection
  11. Impact of Japanese Encephalitis in Adults: Risk Factors and Associated Challenges
  12. Insights into the Japanese encephalitis virus-Mediated Acute Encephalitis Syndrome
  13. Japanese Encephalitis
  14. Laboratory Diagnosis of Japanese Encephalitis
  15. Molecular Diagnostics for Viral Diseases
  16. Molecular and Cellular Mechanisms Underlying Neuropathogenesis of Japanese Encephalitis
  17. Structure, Genome Organization, and Replication of Japanese encephalitis virus
  18. Survivors of Japanese Encephalitis and Associated Neuropsychiatric Complications
  19. Transmission Dynamics of Japanese encephalitis virus
  20. Transplacental Transmission of Japanese encephalitis virus
  21. Treatment Options and Antiviral Drug Discovery for Japanese Encephalitis
  22. Vaccines for Japanese Encephalitis
  23. Artificial Intelligence and Blockchain in Precision Medicine and Virology
  24. COVID-19 and Neurodegenerative Diseases: One Health Approach
  25. One Health Approach - Advancing Global Health Security with the Sustainable Development Goals
  26. Viral Infectious Diseases Annual Volume 2024
  27. Structure-based drug designing for potential antiviral activity of selected natural product against Monkeypox (Mpox) virus and its host targets
  28. Neprilysin-Mediated Amyloid Beta Clearance and Its Therapeutic Implications in Neurodegenerative Disorders
  29. Re-emerging Chandipura vesiculovirus: A cause of concern for global health
  30. Appraisal of skeletal maturity indicators with respect to non-invasive biomarkers
  31. WSV2023 - The second meeting of the world society for virology: One health - One world - One virology
  32. Unravelling the interaction between Influenza virus and the nuclear pore complex: insights into viral replication and host immune response
  33. Desloratadine via its anti-inflammatory and antioxidative properties ameliorates TNBS-induced experimental colitis in rats
  34. HIV Treatment - New Developments
  35. Editorial: Viral emerging and re-emerging diseases: basic understanding and future intervention strategies
  36. Comparative analysis of salivary microbiota in diabetic and non-diabetic individuals of North India using metagenomics
  37. Role of Artificial Intelligence, Telehealth, and Telemedicine in Medical Virology
  38. Antiviral Strategies in the Treatment of Human and Animal Viral Infections
  39. SARS-CoV-2 Infection, Inflammation, Immunonutrition, and Pathogenesis of COVID-19
  40. Neuroprotective Effect of Levetiracetam in Combination with Berberine on Scopolamine Induced-Cognitive Impairment in Mice: A Behavioral and Biochemical Approach
  41. Transforming clinical virology with AI, machine learning and deep learning: a comprehensive review and outlook
  42. Understanding HIV-associated neurocognitive and neurodegenerative disorders (neuroAIDS): enroute to achieve the 95-95-95 target and sustainable development goal for HIV/AIDS response
  43. Appraisal of skeletal maturity indicators with respect to non invasive biomarkers
  44. Introductory Chapter: Recent Trends in Emerging and Reemerging Viral Contagions – The Day after Today
  45. Viral Outbreaks - Global Impact and Newer Horizons
  46. Dengue Fever in a One Health Perspective - Latest Research and Recent Advances
  47. Tracking the COVID-19 vaccines: The global landscape
  48. Current Topics in SARS-CoV-2/COVID-19 - Two Years After
  49. Antiviral and anti‐inflammatory activity of natural compounds against Japanese encephalitis virus via inhibition of NS5 protein and regulation of key immune and inflammatory signaling pathways
  50. Future Opportunities and Tools for Emerging Challenges for HIV/AIDS Control
  51. Antiviral and anti-inflammatory activity of novel belladonna formulation against Japanese encephalitis virus via inhibition of p65 nuclear translocation and TNF-α mediated NF-kB signaling
  52. Artificial Intelligence in Medical Virology
  53. Infectious Diseases Annual Volume 2022
  54. Fabrication and Evaluation of Basil Essential Oil-Loaded Halloysite Nanotubes in Chitosan Nanocomposite Film and Its Application in Food Packaging
  55. Pre-clinical investigation of protective effect of nutraceutical D-glucosamine on TNBS-induced colitis
  56. Tracing the origin of Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2): A systematic review and narrative synthesis
  57. Re‐emerging human monkeypox: A major public‐health debacle
  58. Trends in Molecular Aspects and Therapeutic Applications of Drug Repurposing for Infectious Diseases
  59. Drug Repurposing - Molecular Aspects and Therapeutic Applications
  60. Introductory Chapter: High-Throughput Screening - A New Tool for Precision Medicine
  61. High-Throughput Screening for Drug Discovery toward Infectious Diseases: Options and Challenges
  62. High-Throughput Screening for Drug Discovery
  63. Pneumonia
  64. Progress and Challenges Toward Generation and Maintenance of Long-Lived Memory T Lymphocyte Responses During COVID-19
  65. Chikungunya Virus - A Growing Global Public Health Threat
  66. Association between Adaptive Evolution of the Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein and Geographically Distinct Virus Epidemiology During the Initial Wave of the Coronavirus Disease 2019 Pandemic
  67. Transmission dynamics and mutational prevalence of the novel Severe acute respiratory syndrome coronavirus‐2 Omicron Variant of Concern
  68. Characterization of the novel SARS‐CoV‐2 Omicron (B.1.1.529) variant of concern and its global perspective
  69. Environmental Nanomedicine
  70. Microbicidal Nanoparticles
  71. Epstein-Barr Virus - New Trends
  72. Structural and molecular perspectives of SARS-CoV-2
  73. Therapeutic approaches for SARS-CoV-2 infection
  74. Innate Immunity in Health and Disease
  75. Pathogenesis and Host Immune Response during Japanese Encephalitis Virus Infection
  76. Multi-Organ Involvement in COVID-19: Beyond Pulmonary Manifestations
  77. Wound Healing Activity of a Novel Formulation SKRIN via Induction of Cell Cycle Progression and Inhibition of PCNA–p21 Complex Interaction Leading to Cell Survival and Proliferation
  78. Artificial Intelligence in Mental Healthcare During COVID-19 Pandemic
  79. Artificial Intelligence-Enabled Prognosis Technologies for SARS-CoV-2/COVID-19
  80. Use of Mobile Phone Apps for Contact Tracing to Control the COVID-19 Pandemic: A Literature Review
  81. Role of metabolomics in identifying cardiac hypertrophy: an overview of the past 20 years of development and future perspective
  82. Applications of Artificial Intelligence in COVID-19
  83. Zika Virus Disease: Progress and Prospects
  84. An Ophthalmological update for air-travellers during COVID-19
  85. The relevance of digital mental healthcare during COVID-19: Need for innovations
  86. Chasing COVID-19 through SARS-CoV-2 spike glycoprotein
  87. COVID-19 in the elderly people and advances in vaccination approaches
  88. Plant-based vaccines and antibodies to combat COVID-19: current status and prospects
  89. Recombinant vaccines for COVID-19
  90. Dengue Fever in a One Health Perspective
  91. Antiviral activity of traditional medicinal plants from Ayurveda against SARS-CoV-2 infection
  92. Antiviral Activity of Belladonna During Japanese Encephalitis Virus Infection via Inhibition of Microglia Activation and Inflammation Leading to Neuronal Cell Survival
  93. Mental illnesses among COVID-19 patients: Possible immunological underpinnings
  94. Viral Hepatitis E and Chronicity: A Growing Public Health Concern
  95. COVID-19: benefits and risks of passive immunotherapeutics
  96. Calcarea carbonica treatment rescues lipopolysaccharide-induced inflammatory response in human mononuclear cells via downregulation of inducible cyclooxygenase pathway
  97. Dark Classics in Chemical Neuroscience: An Evidence-Based Systematic Review of Belladonna
  98. Clinical Management and Therapeutic Strategies for the Thyroid-Associated Ophthalmopathy: Current and Future Perspectives
  99. Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor
  100. Hepatitis B and C
  101. High sensitivity C-reactive protein level in cerebrovascular accident
  102. Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV)
  103. Comparative analysis of Hemagglutinin of 2013 H3N2 Influenza A virus Indicates its Evolution from 1968 H3N2 Pandemic Influenza A virus
  104. Use of Mobile Phone Apps for Contact Tracing to Control the COVID-19 Pandemic: A Literature Review
  105. Next-Generation Rapid Advanced Molecular Diagnostics of COVID-19 by CRISPR-Cas
  106. A demographic prevalence of β Thalassemia carrier and other hemoglobinopathies in adolescent of Tharu population
  107. Animal Flaviviruses
  108. COVID-19: An Ophthalmological Update
  109. Classical Coronaviruses
  110. Clinical Characteristics and Differential Clinical Diagnosis of Novel Coronavirus Disease 2019 (COVID-19)
  111. Contemporary vaccine approaches and role of next-generation vaccine adjuvants in managing viral diseases
  112. Coping with Mental Health Challenges During COVID-19
  113. Coronavirus Disease 2019 (COVID-19)
  114. Coronavirus Infection Among Children and Adolescents
  115. Correction to: Transmission Cycle of SARS-CoV and SARS-CoV-2
  116. Current Advances in Nanotechnology and Medicine
  117. Current Insight into the Novel Coronavirus Disease 2019 (COVID-19)
  118. Diagnostic Strategies for COVID-19 and other Coronaviruses
  119. Emergence and Reemergence of Severe Acute Respiratory Syndrome (SARS) Coronaviruses
  120. Futuristic Technologies for Advanced Detection, Prevention, and Control of COVID-19
  121. Global Trends in Epidemiology of Coronavirus Disease 2019 (COVID-19)
  122. Host Immune Response and Immunobiology of Human SARS-CoV-2 Infection
  123. Laboratory Diagnosis of Novel Coronavirus Disease 2019 (COVID-19) Infection
  124. Modern Approaches in Nanomedicine for NeuroAIDS and CNS Drug Delivery
  125. Morphology, Genome Organization, Replication, and Pathogenesis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
  126. NanoBioMedicine
  127. Nanotoxicology in Medicine
  128. Negative COVID-19 Test: What Next?
  129. Nipah Virus
  130. Opportunities in Clinical Translation and Commercialization of Nanomedicine
  131. Pandemic Influenza A Virus (pH1N1)
  132. Preparing Children for Pandemics
  133. Preparing for the Perpetual Challenges of Pandemics of Coronavirus Infections with Special Focus on SARS-CoV-2
  134. Prevention and Control Strategies for SARS-CoV-2 Infection
  135. Radiological Perspective of the Novel Coronavirus Disease 2019 (COVID-19)
  136. Therapeutic Development and Drugs for the Treatment of COVID-19
  137. Transmission Cycle of SARS-CoV and SARS-CoV-2
  138. Water-Associated Infectious Diseases
  139. Malaria
  140. Current Topics in Neglected Tropical Diseases
  141. The Global Distribution and Burden of Dengue and Japanese Encephalitis Co-Infection in Acute Encephalitis Syndrome
  142. Complementary and Alternative Medicine Treatments of Water-Associated Infectious Diseases in Alliance with Conventional Medicine Treatments
  143. Conventional Treatments of Water-Associated Infectious Diseases
  144. Emerging and Re-emerging Water-Associated Infectious Diseases
  145. Epidemiology of Water-Associated Infectious Diseases
  146. Etiological Agents of Water-Associated Infectious Diseases
  147. Evolution and Interplay of Water-Associated Human Pathogens
  148. Global Strategies and Schemes for Preventing Water-Associated Infectious Diseases
  149. Hazards Associated with Contaminated Water
  150. Impact of Climate Change on Water-Associated Infectious Diseases
  151. Introduction to Water-Associated Infectious Diseases
  152. Novel Approaches for Detecting Water-Associated Pathogens
  153. Treatment of Water to Prevent Water-Associated Infectious Diseases
  154. Correlation of Cytogenetic, Molecular and Clinical Findings in Thalassemia Patients at a Tertiary Care Hospital
  155. Hydroxyapatite–collagen augments osteogenic differentiation of dental pulp stem cells
  156. Cytogenetic Analysis of Down Syndrome Patients in Eastern Uttar Pradesh.
  157. Current Perspectives in Human Papillomavirus
  158. Recent Advances in Human Papillomavirus Infection and Management
  159. Pathogen-associated acute encephalitis syndrome: therapeutics and management
  160. Zika virus disease in India - Update October 2018
  161. Introductory Chapter: Human Influenza A Virus Infection - Global Prevalence, Prevention, Therapeutics, and Challenges
  162. Influenza - Therapeutics and Challenges
  163. Global Perspective of Novel Therapeutic Strategies for the Management of NeuroAIDS
  164. Introductory Chapter: Neglected Tropical Waterborne Infectious Diseases - Strategies for Mitigation
  165. Nanocarriers for brain specific delivery of anti-retro viral drugs: challenges and achievements
  166. Complementary and alternative medicine in alliance with conventional medicine for dengue therapeutics and prevention
  167. Reducing the Global Burden of Dengue: Steps toward Preventive Methods
  168. Mesenchymal stem cells in regenerative medicine: a new paradigm for degenerative bone diseases
  169. Current Advances in Zika Virus Transmission: Urgency for Effective Therapeutics and Prevention
  170. Complementary and alternative medicine in alliance with conventional medicine for influenza therapeutics and prevention
  171. Proof and Concepts in Rapid Diagnostic Tests and Technologies
  172. Introductory Chapter: Serum Components as Rapid Diagnostic Biomakers During Flavivirus Infection
  173. Emerging Zika virus disease: a public health emergency of global concern
  174. Advances in Molecular Retrovirology
  175. Molecular Biology and Pathogenesis of Retroviruses
  176. Zika virus outbreak: an overview of the experimental therapeutics and treatment
  177. Investigation of Neuropathogenesis in HIV-1 Clade B and C Infection Associated with IL-33 and ST2 Regulation
  178. Interactive effects of cocaine on HIV infection: implication in HIV-associated neurocognitive disorder and neuroAIDS
  179. Japanese encephalitis: a major public-health debacle
  180. Japanese Encephalitis: A Neglected Viral Disease and Its Impact on Global Health
  181. Trends in Infectious Diseases
  182. CURRENT SCENARIO OF THERAPEUTICS FOR EBOLA VIRUS DISEASE
  183. An insight into flaviviral budding: a need to know more
  184. Towards nanomedicines for neuroAIDS
  185. Vorinostat positively regulates synaptic plasticity genes expression and spine density in HIV infected neurons: role of nicotine in progression of HIV-associated neurocognitive disorder
  186. Current Scenario of Antiviral Drugs for Japanese Encephalitis
  187. Cocaine Enhances HIV-1 Infectivity in Monocyte Derived Dendritic Cells by Suppressing microRNA-155
  188. Latency, persistence and reactivation of Japanese encephalitis virus
  189. Targeted Brain Derived Neurotropic Factors (BDNF) Delivery across the Blood-Brain Barrier for Neuro-Protection Using Magnetic Nano Carriers: An In-Vitro Study
  190. Current Perspectives in HIV Infection
  191. NeuroAIDS: Mechanisms, Causes, Prevalence, Diagnostics and Social Issues
  192. Latest trends in drugs of abuse – HIV infection and neuroAIDS
  193. Japanese Encephalitis Virus: The Complex Biology of an Emerging Pathogen
  194. Influenza A(H1N1)pdm09 virus: therapeutics and challenges
  195. A Global Perspective on HIV/AIDS
  196. Nanotherapeutics: emerging competent technology in neuroAIDS and CNS drug delivery
  197. Modulation of HIV pathogenesis and T-cell signaling by HIV-1 Nef
  198. Targeting Strategies for Human Immunodeficiency Virus: A Combinatorial Approach
  199. HIV-1 Nef: hacker of the host cell
  200. Rendezvous with Tat: Transactivator of Transcription during Human Immunodeficiency Virus Pathogenesis
  201. Japanese Encephalitis: A Persistent Threat
  202. The Intolerable Burden of Chikungunya: What’s New, What’s Needed?
  203. Interactive Effects of Morphine on HIV Infection: Role in HIV-Associated Neurocognitive Disorder
  204. JAPANESE ENCEPHALITIS VIRUS: AN EMERGING PATHOGEN
  205. Japanese Encephalitis: An Emerging and Spreading Arbovirosis
  206. HIV-1 Tat upregulates expression of histone deacetylase-2 (HDAC2) in human neurons: Implication for HIV-associated neurocognitive disorder (HAND)
  207. Human immunodeficiency virus type 1 clade B and C Tat differentially induce indoleamine 2,3-dioxygenase and serotonin in immature dendritic cells: Implications for neuroAIDS
  208. Interactive role of human immunodeficiency virus type 1 (HIV-1) clade-specific Tat protein and cocaine in blood-brain barrier dysfunction: Implications for HIV-1–associated neurocognitive disorder
  209. Pharmacophore-based virtual screening and docking studies on Hsp90 inhibitors
  210. Escalation of Japanese encephalitis in India: Evidence from 2005 viral encephalitis outbreak and appraisal of niceties
  211. Molecular modelling and docking studies on heat shock protein 90 (Hsp90) inhibitors
  212. Structural and antigenic variance between novel influenza A/H1N1/2009 and influenza A/H1N1/2008 viruses
  213. Swine flu: Influenza A/H1N1 2009: the unseen and unsaid
  214. Trend of Japanese encephalitis in North India: evidence from thirty-eight acute encephalitis cases and appraisal of niceties
  215. Advances in antiviral drug discovery and development: Part II: Advancements in antiviral drug development
  216. Controversial role of smallpox on historical positive selection at the CCR5 chemokine gene (CCR5-Δ32)
  217. Paromomycin: Uptake and resistance in Leishmania donovani
  218. Advances in antiviral drug discovery and development: Part I: Advancements in antiviral drug discovery
  219. The Latitude Wise Prevalence of the CCR5-Δ32-HIV Resistance Allele in India
  220. Japanese encephalitis: perspectives and new developments
  221. Enzymatic and Structural Characterisation of Amphinase, a Novel Cytotoxic Ribonuclease from Rana pipiens Oocytes
  222. Re-emergence of the knotty chikungunya virus: facts, fear or fiction
  223. Differential HIV-1 replication in neonatal and adult blood mononuclear cells is influenced at the level of HIV-1 gene expression
  224. Co-administration of IL-12 DNA with rORFF antigen confers long-term protective immunity against experimental visceral leishmaniaisis
  225. Reply to 'Encephalitis outbreak finds Indian officials unprepared'
  226. A Heterologous Prime‐Boost Vaccination Regimen Using ORFF DNA and Recombinant ORFF Protein Confers Protective Immunity against Experimental Visceral Leishmaniasis
  227. Immunostimulatory oligodeoxynucleotides are potent enhancers of protective immunity in mice immunized with recombinant ORFF leishmanial antigen
  228. ONCONASE ® and Its Therapeutic Potential
  229. Inhibition of Japanese Encephalitis Virus Infection by Diethyldithiocarbamate is Independent of its Antioxidant Potential
  230. Vaccination with DNA encoding ORFF antigen confers protective immunity in mice infected with Leishmania donovani
  231. Alteration in plasma glucose levels in Japanese encephalitis patients
  232. Entry into Cells and Selective Degradation of tRNAs by a Cytotoxic Member of the RNase A Family
  233. Induction of Nitric Oxide Synthase during Japanese Encephalitis Virus Infection: Evidence of Protective Role
  234. Antiviral effect of nitric oxide during Japanese encephalitis virus infection
  235. Regulation of intestinal regeneration: New insights
  236. Interferon Enhances the Activity of the Anticancer Ribonuclease, Onconase
  237. Engineering receptor-mediated cytotoxicity into human ribonucleases by steric blockade of inhibitor interaction
  238. Isolation of Desulfovibrio intestinalis sp. nov. from the hindgut of the lower termite Mastotermes darwiniensis
  239. Degradation of Japanese encephalitis virus by neutrophils
  240. Role of Organized Intestinal Lymphoid Aggregates in Intestinal Regeneration
  241. Inhibition of HIV-1 Production and Selective Degradation of Viral RNA by an Amphibian Ribonuclease
  242. Role of the N Terminus in RNase A Homologues: Differences in Catalytic Activity, Ribonuclease Inhibitor Interaction and Cytotoxicity
  243. A Study of the Intracellular Routing of Cytotoxic Ribonucleases
  244. Epithelial cell proliferation and biodistribution of radiolabeled urogastrone in the gastrointestinal mucosa of young and old mice
  245. Lignocellulose degradation by microorganisms from termite hills and termite guts: A survey on the present state of art
  246. Effect of systematic interleukin-3 administration on epithelial cell proliferation in mouse intestine
  247. Extent and Role of Urogastrone in the Adaptive Response of Rat Intestine to Patching of a Surgical Defect in the Ileum
  248. Ultrastructural studies of the termite (Odontotermes obesus) gut microflora and its cellulolytic properties
  249. Association of radiolabeled urogastrone binding with regenerating intestinal mucosa and epidermal growth factor/ urogastrone producing organs in rat
  250. Effect of cobalt and nickel on growth and carboxymethyl cellulase activity ofCellulomonas spp
  251. Production and localisation of carboxymethylcellulase, xylanase and ?-glucosidase fromCellulomonas andMicrococcus spp.
  252. The Effect of Intestinal Resection and Urogastrone on Intestinal Regeneration
  253. Ethanol Has Direct Inhibitory Effects on Steroidogenesis in Human Granulosa Cells: Specific Inhibition of LH Action
  254. Effect of age on intestinal regeneration in the rabbit
  255. Effect of Eflorithine on Intestinal Regeneration